Congress Asset Management Co. Buys 34,328 Shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC)

Congress Asset Management Co. grew its position in Acadia Healthcare Company, Inc. (NASDAQ:ACHC) by 24.7% in the first quarter, according to its most recent filing with the SEC. The fund owned 173,517 shares of the company’s stock after acquiring an additional 34,328 shares during the period. Congress Asset Management Co. owned 0.19% of Acadia Healthcare worth $5,261,000 as of its most recent filing with the SEC.

Other large investors also recently modified their holdings of the company. Lindbrook Capital LLC grew its stake in shares of Acadia Healthcare by 1,342.0% in the 4th quarter. Lindbrook Capital LLC now owns 721 shares of the company’s stock valued at $29,000 after buying an additional 671 shares during the period. Blue Trust Inc. raised its holdings in shares of Acadia Healthcare by 69.4% in the 4th quarter. Blue Trust Inc. now owns 842 shares of the company’s stock worth $33,000 after purchasing an additional 345 shares during the period. Signaturefd LLC raised its holdings in shares of Acadia Healthcare by 460.6% in the 4th quarter. Signaturefd LLC now owns 1,222 shares of the company’s stock worth $48,000 after purchasing an additional 1,004 shares during the period. Quadrant Capital Group LLC raised its holdings in Acadia Healthcare by 287.1% during the 4th quarter. Quadrant Capital Group LLC now owns 1,258 shares of the company’s stock valued at $50,000 after acquiring an additional 933 shares during the period. Finally, State of Wyoming bought a new stake in Acadia Healthcare during the 4th quarter valued at $56,000.

Acadia Healthcare Price Performance

Acadia Healthcare stock opened at $22.74 on Monday. Acadia Healthcare Company, Inc. has a 1 year low of $20.36 and a 1 year high of $82.41. The company’s 50 day simple moving average is $24.33 and its 200-day simple moving average is $33.69. The company has a market capitalization of $2.09 billion, a price-to-earnings ratio of 7.46, a price-to-earnings-growth ratio of 1.46 and a beta of 0.94. The company has a debt-to-equity ratio of 0.60, a quick ratio of 1.07 and a current ratio of 1.07.

Acadia Healthcare (NASDAQ:ACHC) last issued its earnings results on Monday, May 12th. The company reported $0.40 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.35 by $0.05. The business had revenue of $770.51 million during the quarter, compared to analysts’ expectations of $769.90 million. Acadia Healthcare had a net margin of 8.99% and a return on equity of 11.12%. The company’s revenue for the quarter was up .3% on a year-over-year basis. During the same quarter in the prior year, the business posted $0.84 EPS. As a group, equities research analysts expect that Acadia Healthcare Company, Inc. will post 3.38 earnings per share for the current year.

Analysts Set New Price Targets

Several research analysts recently issued reports on the stock. Barclays lowered their price target on shares of Acadia Healthcare from $35.00 to $28.00 and set an “equal weight” rating for the company in a research note on Wednesday, May 14th. Wall Street Zen raised shares of Acadia Healthcare from a “sell” rating to a “hold” rating in a research note on Thursday, May 22nd. Royal Bank of Canada cut their price objective on shares of Acadia Healthcare from $64.00 to $43.00 and set an “outperform” rating on the stock in a report on Monday, March 3rd. Stephens upgraded shares of Acadia Healthcare to a “hold” rating in a report on Monday, June 2nd. Finally, Mizuho cut their price target on shares of Acadia Healthcare from $37.00 to $32.00 and set a “neutral” rating on the stock in a report on Wednesday, May 14th. Five investment analysts have rated the stock with a hold rating and six have issued a buy rating to the company. Based on data from MarketBeat.com, Acadia Healthcare has a consensus rating of “Moderate Buy” and an average target price of $47.94.

Acadia Healthcare Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.